-
Department of Pathology started functioning from the year 1954 since the inception of our prestigious institution.
-
Our diagnostic services include histopathology, cytopathology, hematopathology, clinical pathology, 24 hours central lab and highly specialized services like immunohistochemistry and frozen biopsies reporting over 15,000 cases in histopathology, 5,000 cases in cytopathology and 45,000 cases in hematopathology annually.
-
Our department also aims at imparting best knowledge to the undergraduate and postgraduate medical students, B.Sc. Nursing, B.Sc. Allied health , B.Sc. MLT, DMLT, B. Pharm and D. Pharm students inspiring them to come out with flying colours as good health care professionals.
-
Our annual postgraduate intake has increased from two to eight MD postgraduate seats since 2021.
-
We are planning to establish a molecular diagnostics laboratory in the near future.
-
As Pathology is a fast updating field, we strive hard to keep ourselves updated in knowledge and skills by conducting regular CMEs for undergraduate and postgraduate students, journal clubs, clinicopathologic case discussions and integrated learning sessions.
-
The smooth functioning of the services provided is made possible with the help our HOD, professors, associate professors, assistant professors, postgraduates and the laboratory technicians team.
Dr. G. Meenakumari
Professor and HOD
Qualification : M.D., Pathology
Clinical workload of the Pathology Department:
|
Nature of Specimens |
On the day of Assessment |
Year 1 |
Year 2 |
Year 3 (2024) |
|
(1) |
(2) |
(3) |
(4) |
(5) |
|
Total number of histopathology investigations [(Total specimens (Organ/Part/Tissue)] for histopathology received and reported * |
10212 |
15034 |
15806 |
|
|
Frozen sections |
68 |
83 |
44 |
|
|
Special stains (give details below in brief) |
192 |
204 |
133 |
|
|
Immunohistochemistry (mention below if outsourced) |
726 |
816 |
1012 |
|
|
Total Hematology Specimen received and tested |
431424 |
527086 |
643975 |
|
|
Total Cytopathology Specimen received and reported (Cytopathology workload) |
18733 |
18980 |
23867 |
|
|
Fluid Cytology |
737 |
952 |
1522 |
|
|
Exfoliative Cytology |
1732 |
2817 |
5226 |
|
|
FNAC (Direct) |
2883 |
2540 |
3416 |
|
|
FNAC (CT guided) |
5 |
11 |
18 |
|
|
FNAC (USG guided) |
43 |
34 |
86 |
|
|
PBF |
24760 |
23677 |
23263 |
|
|
Bone marrow |
883 |
977 |
1021 |
. Histopathology
Types of histopathological reports by the Department of Pathology:
|
Nature of Disease Reported |
||||
|
On the day of Assessment |
Year 1 |
Year 2 |
Year 3 (2024) |
|
|
Tuberculosis |
280 |
413 |
423 |
|
|
Other infections/ Inflammations |
5762 |
6153 |
6120 |
|
|
Benign/Non Neoplastic* |
5197 |
4175 |
4495 |
|
|
Malignancies |
2568 |
2252 |
2818 |
|
|
Others (specify) |
1778 |
1458 |
1950 |
Note: * Tuberculosis and Other infections/inflammations to be excluded here.
f. Hematology:
-
Total Hematology samples received and tested: 643975 (for the year 2024)
-
Number of Investigations:
|
Name of test |
Total Numbers |
|||
|
Number on day of Assessment |
Year1 |
Year2 |
Year3 (2024) |
|
|
CBC |
234651 |
384681 |
471929 |
|
|
ESR |
34054 |
35280 |
38820 |
|
|
Reticulocyte Count |
4102 |
2657 |
3900 |
|
|
Absolute Eosinophil Count |
633 |
933 |
883 |
|
|
Bone Marrow Aspiration |
889 |
866 |
899 |
|
|
Bone Marrow Biopsy |
72 |
107 |
122 |
|
|
PT, Aptt, TT |
45638 |
65377 |
89970 |
|
-
Facilities for the work up of the following (Name of investigation & numbers per year):
|
Name of the Test |
Number on day of Assessment |
Year1 |
Year2 |
Year3 (2024) |
|
Coagulation Disorders |
6068 |
6247 |
6345 |
|
|
Leukemia |
534 |
834 |
893 |
|
|
Nutritional Anemias |
3709 |
5696 |
5876 |
|
|
Hemolytic Anemias |
73 |
106 |
112 |
g. Body Fluids (Clinical Pathology):
|
Name of the Test |
Number on Day of Assessment |
Year 1 |
Year 2 |
Year 3 (2024) |
|
Urine: Routine |
88580 |
78799 |
95474 |
|
|
Urine Special: |
7866 |
6100 |
5363 |
|
|
Semen: Routine |
302 |
325 |
298 |
|
|
Semen: Special |
NIL |
NIL |
Nil |
|
|
CSF |
63 |
62 |
70 |
|
|
Sputum: |
5467 |
6176 |
5968 |
|
|
Other body fluids: |
619 |
832 |
1873 |
CME PROGRAMME
Awards:
Postgraduate
Dr.Deepthi - University gold medal
Undergraduate
Apsara - First prize,Kanyakumari hemat quiz
Bavisha - First prize,Kanyakumari hemat quiz
Akshaya Deepam - First prize,Kanyakumari hemat quiz
Events:
| MD 2022-2023 | View |
| MD 2023-2024 | View |
| MD 2024-2025 | View |
POSTGRADUATE STUDENTS LIST 2025 - 2026:
| S.No | Year | Name of Student |
|---|---|---|
| 1 | First Year | Dr. A. Kaviya |
| 2 | First Year | Dr. R. Babyrajaselvam |
| 3 | First Year | Dr. M. S. Aarthy |
| 4 | First Year | Dr. S. Pandiselvi |
| 5 | First Year | Dr. D. Jayasree Sai |
| 6 | First Year | Dr. M. Sanjeevi Raj |
| 7 | First Year | Dr. A. Shanmathy |
| 8 | Second Year | Dr. H. Imran |
| 9 | Second Year | Dr. M. Sivaranjani |
| 10 | Second Year | Dr. E. Niranjana |
| 11 | Second Year | Dr. J. Pavithra |
| 12 | Second Year | Dr. M. Harini |
| 13 | Second Year | Dr. M. Gowsalya |
| 14 | Second Year | Dr. M. Anitha Devi |
| 15 | Second Year | Dr. A. Uma |
| 16 | Third Year | Dr. Nivethakumari |
| 17 | Third Year | Dr. Hemaveena |
| 18 | Third Year | Dr. S. Janani Nivenitha |
| 19 | Third Year | Dr. Prabhakar |
| 20 | Third Year | Dr. M. Shalini |
| 21 | Third Year | Dr. Balaguru Divya |
| 22 | Third Year | Dr. M. Kiruthika |
| 23 | Third Year | Dr. A. Karthiga |
| 24 | Third Year | Dr. Anugayathri |
RESEARCH ACTIVITIES – POSTGRADUATE STUDENTS
| Cadre | Name | Research Completed | Research Ongoing |
|---|---|---|---|
| Postgraduate – Final Year | Dr. Hemaveena | — | An analysis of immunoexpression of HER2neu in gastric carcinoma and its correlation with histopathological subtypes |
| Postgraduate – Final Year | Dr. S. Janani Nivenitha | — | Role of C4d immunohistochemical marker studies in the diagnosis of bullous pemphigoid |
| Postgraduate – Final Year | Dr. Nivethakumari | — | Evaluation of androgen receptor expression in urothelial carcinoma of bladder – A hospital-based cohort study |
| Postgraduate – Final Year | Dr. Prabhakar | — | Status of IHC marker ezrin in colorectal cancer: pathological perspectives and prognostic values in a tertiary care centre |
| Postgraduate – Final Year | Dr. Shalini | — | Correlation of folate alpha receptor expression with the clinicopathological parameters and outcomes in epithelial ovarian cancers |
| Postgraduate – Final Year | Dr. Balaguru Divya | — | Aberrant expression of beta catenin in triple negative breast cancer and its correlation with histomorphological grading |
| Postgraduate – Final Year | Dr. M. Kiruthika | — | Analysis of immunohistochemical expression of programmed death protein ligand (PDL1) in Hodgkin and non-Hodgkin lymphoma |
| Postgraduate – Final Year | Dr. Anugayathri | — | Role of PIK3CA immunohistochemical marker in invasive breast cancer |
| Postgraduate – Final Year | Dr. A. Karthiga | — | Clinical histomorphological and immunohistochemical characteristics of periampullary carcinoma with focus on SMAD4 expression – A hospital-based cohort study |
| Postgraduate – Second Year | Dr. J. Pavithra | — | Diagnostic role of TRPS1 and GATA3 expression in triple negative primary and metastatic breast cancer |
| Postgraduate – Second Year | Dr. M. Sivaranjani | — | Clinico pathological significance of mismatch repair protein expression and tumour budding in colorectal carcinoma in tertiary care centre |
| Postgraduate – Second Year | Dr. Gowsalya M | — | The role of immunohistochemical marker Matrix Metalloproteinase-9 in grading of oral squamous cell carcinoma and its correlation with nodal metastasis |
| Postgraduate – Second Year | Dr. Imran | — | Evaluation of claudin 18.2 expression and its clinicopathological correlation in gastric adenocarcinoma |
| Postgraduate – Second Year | Dr. Niranjana | — | Expression of COX2 in endometrial carcinoma and its correlation with p53 expression |
| Postgraduate – Second Year | Dr. Harini | — | Correlation of PD-L1 and MMR status in endometrial carcinoma |
| Postgraduate – Second Year | Dr. Uma | — | ERG expression in prostatic carcinoma |
| Postgraduate – Second Year | Dr. Anitha | — | Analysis of IHC PSTAT3 in diagnosis and prognosis of squamous cell carcinoma of cervix |